Nemocnica Ziar nad Hronom a Banska Stiavnica s.r.o.
- Address
- lock Available on a paid plan
Nemocnica Ziar nad Hronom a Banska Stiavnica s.r.o. - Cerebrovascular and Stroke Research
Nemocnica Ziar nad Hronom a Banska Stiavnica s.r.o. is a medical facility engaged in advanced clinical research focused on cerebrovascular disease prevention and stroke management. The center participates in cutting-edge international studies investigating novel therapeutic approaches for patients at high risk of recurrent cerebrovascular events.
- Prevention of recurrent ischemic stroke following acute non-cardioembolic stroke events
- Management and prevention strategies for high-risk transient ischemic attacks (mini strokes)
- Evaluation of innovative anticoagulation therapies including FXIa inhibitors combined with antiplatelet therapy
The research center demonstrates expertise in evaluating both the efficacy and safety profiles of novel stroke prevention therapies. Their clinical trial portfolio includes investigations into oral FXIa inhibitors as an alternative to traditional anticoagulation approaches, with particular emphasis on minimizing major bleeding complications while maximizing protection against recurrent ischemic events in vulnerable patient populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Nemocnica Ziar nad Hronom a Banska Stiavnica s.r.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Asundexian for Ischemic Stroke Prevention in Adults Post-Acute Non-Cardioembolic Stroke or High-Risk TIA | Bayer AG | Phase III | Not Recruiting | Jan 2023 | Oct 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Asundexian | 1 | Unknown | 2023-01-18 | 2023-01-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.